VNOV — Vitanova Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $35.43m
- $33.83m
- $3.03m
Annual cashflow statement for Vitanova Life Sciences, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | 2026 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.14 | -0.024 | 0.141 | 0.851 | -0.037 |
| Deferred Taxes | |||||
| Non-Cash Items | -0.153 | 0 | 0.001 | 0.007 | 0.241 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.017 | 0.006 | -0.518 | -0.664 | 0.627 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 0.004 | -0.018 | -0.376 | 0.193 | 0.814 |
| Financing Cash Flow Items | 0.019 | 0.004 | 0.96 | -0.003 | 0 |
| Other Financing Cash Flow | |||||
| Cash from Financing Activities | 0.019 | 0.004 | 0.96 | -0.003 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.023 | -0.014 | 0.584 | 0.19 | 0.814 |